Annual Total Liabilities
$71.98 M
+$37.68 M+109.84%
December 31, 2023
Summary
- As of February 7, 2025, APLT annual total liabilities is $71.98 million, with the most recent change of +$37.68 million (+109.84%) on December 31, 2023.
- During the last 3 years, APLT annual total liabilities has risen by +$49.41 million (+218.96%).
- APLT annual total liabilities is now at all-time high.
Performance
APLT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$100.67 M
+$45.29 M+81.77%
September 30, 2024
Summary
- As of February 7, 2025, APLT quarterly total liabilities is $100.67 million, with the most recent change of +$45.29 million (+81.77%) on September 30, 2024.
- Over the past year, APLT quarterly total liabilities has increased by +$44.44 million (+79.01%).
- APLT quarterly total liabilities is now at all-time high.
Performance
APLT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
APLT Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +109.8% | +79.0% |
3 y3 years | +219.0% | +216.1% |
5 y5 years | +80.7% | +537.9% |
APLT Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +163.2% | at high | +337.9% |
5 y | 5-year | at high | +356.1% | at high | +901.3% |
alltime | all time | at high | +893.2% | at high | +1444.8% |
Applied Therapeutics Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $100.67 M(+81.8%) |
Jun 2024 | - | $55.39 M(-34.0%) |
Mar 2024 | - | $83.94 M(+16.6%) |
Dec 2023 | $71.98 M(+109.8%) | $71.98 M(+28.0%) |
Sep 2023 | - | $56.24 M(+17.2%) |
Jun 2023 | - | $47.98 M(+40.8%) |
Mar 2023 | - | $34.08 M(-0.7%) |
Dec 2022 | $34.30 M(+25.4%) | $34.30 M(-27.1%) |
Sep 2022 | - | $47.05 M(-10.2%) |
Jun 2022 | - | $52.37 M(+127.8%) |
Mar 2022 | - | $22.99 M(-16.0%) |
Dec 2021 | $27.35 M | $27.35 M(-14.1%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $31.85 M(+29.9%) |
Jun 2021 | - | $24.52 M(+16.8%) |
Mar 2021 | - | $21.00 M(-7.0%) |
Dec 2020 | $22.57 M(+43.0%) | $22.57 M(+3.1%) |
Sep 2020 | - | $21.90 M(+7.5%) |
Jun 2020 | - | $20.37 M(+102.6%) |
Mar 2020 | - | $10.05 M(-36.3%) |
Dec 2019 | $15.78 M(-60.4%) | $15.78 M(+142.2%) |
Sep 2019 | - | $6.52 M(-3.9%) |
Jun 2019 | - | $6.78 M(-84.9%) |
Mar 2019 | - | $44.79 M(+12.4%) |
Dec 2018 | $39.84 M(+449.7%) | $39.84 M |
Dec 2017 | $7.25 M | - |
FAQ
- What is Applied Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Applied Therapeutics?
- What is Applied Therapeutics annual total liabilities year-on-year change?
- What is Applied Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Applied Therapeutics?
- What is Applied Therapeutics quarterly total liabilities year-on-year change?
What is Applied Therapeutics annual total liabilities?
The current annual total liabilities of APLT is $71.98 M
What is the all time high annual total liabilities for Applied Therapeutics?
Applied Therapeutics all-time high annual total liabilities is $71.98 M
What is Applied Therapeutics annual total liabilities year-on-year change?
Over the past year, APLT annual total liabilities has changed by +$37.68 M (+109.84%)
What is Applied Therapeutics quarterly total liabilities?
The current quarterly total liabilities of APLT is $100.67 M
What is the all time high quarterly total liabilities for Applied Therapeutics?
Applied Therapeutics all-time high quarterly total liabilities is $100.67 M
What is Applied Therapeutics quarterly total liabilities year-on-year change?
Over the past year, APLT quarterly total liabilities has changed by +$44.44 M (+79.01%)